Last reviewed · How we verify
Prevention of Thromboembolism with Chronic Atrial Fibrillation
Approved treatments
- Dabigatran etexilate (DE) · Pfizer Inc.
Dabigatran etexilate (DE) as oral capsule - Pradaxa · Boehringer Ingelheim
Competitive direct thrombin inhibitor preventing fibrin formation and thrombus development. - Coumadin · Generic (originally Wisconsin Alumni Research Foundation)
Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis. - Pradaxa · Generic (originally Boehringer Ingelheim)
Direct thrombin inhibitor that blocks both free and clot-bound thrombin, providing anticoagulation without routine monitoring.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prevention of Thromboembolism with Chronic Atrial Fibrillation patent landscape — cliff calendar, originator estates, attackable patents
- Prevention of Thromboembolism with Chronic Atrial Fibrillation treatment landscape brief
- Prevention of Thromboembolism with Chronic Atrial Fibrillation treatment updates RSS
Frequently asked questions about Prevention of Thromboembolism with Chronic Atrial Fibrillation
What drugs treat Prevention of Thromboembolism with Chronic Atrial Fibrillation?
Tracked treatments include Dabigatran etexilate (DE), Pradaxa, Coumadin.
What is the treatment for Prevention of Thromboembolism with Chronic Atrial Fibrillation?
Standard treatment for Prevention of Thromboembolism with Chronic Atrial Fibrillation includes Dabigatran etexilate (DE), Pradaxa, Coumadin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prevention of Thromboembolism with Chronic Atrial Fibrillation patent cliff · Prevention of Thromboembolism with Chronic Atrial Fibrillation CI report
- Treatment: Dabigatran etexilate (DE) · Pfizer Inc.
- Treatment: Pradaxa · Boehringer Ingelheim
- Treatment: Coumadin · Generic (originally Wisconsin Alumni Research Foundation)
- Treatment: Pradaxa · Generic (originally Boehringer Ingelheim)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing